Pfizer CentreOne Perspectives: Sterile Injectable Capabilities and Responding to Emerging Trends

May 13, 2024

News

Article

Sterile injectables (SI) and complex biologics can be leveraged from both a technical and business development standpoint. Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.

Related Content

Selecting container closure components with confidence: A data-driven approach to container closure integrity

West Pharmaceutical Services

June 13th 2025

Article

Drug products in development require compatible packaging to meet milestones and gain approval. West supports pharmaceutical partners with a data-driven process to give you confidence with closure containment that meets requirements in the modern regulatory landscape.

Nasal Delivery of Spray Dried Biologics: Opportunities & Challenges

Upperton Pharma Solutions

June 13th 2025

Article

Characterisation of Spray Dried Biologics

Upperton Pharma Solutions

June 13th 2025

Article

Spray Drying Biologics: An Alternative to Freeze Drying

Upperton Pharma Solutions

June 13th 2025

Article